PLCXD1 | Phosphatidylinositol-specific phospholipase C, X domain containing 1 | Predicted intracellular proteins
| | | | | Expressed in all |
GTPBP6 | GTP binding protein 6 (putative) | Predicted intracellular proteins
| | | | | Expressed in all |
PPP2R3B | Protein phosphatase 2, regulatory subunit B'', beta | Predicted intracellular proteins
| | | | | Expressed in all |
SHOX | Short stature homeobox | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Not detected |
CRLF2 | Cytokine receptor-like factor 2 | Cancer-related genes Predicted membrane proteins
| | | | | Tissue enhanced |
CSF2RA | Colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) | Cancer-related genes CD markers Disease related genes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
IL3RA | Interleukin 3 receptor, alpha (low affinity) | CD markers FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
SLC25A6 | Solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6 | FDA approved drug targets Mitochondrial proteins Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ASMTL | Acetylserotonin O-methyltransferase-like | Predicted intracellular proteins
| | | | | Expressed in all |
P2RY8 | Purinergic receptor P2Y, G-protein coupled, 8 | Cancer-related genes G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
AKAP17A | A kinase (PRKA) anchor protein 17A | Predicted intracellular proteins
| | | | | Expressed in all |
ASMT | Acetylserotonin O-methyltransferase | Enzymes Predicted intracellular proteins
| | | | | Not detected |
DHRSX | Dehydrogenase/reductase (SDR family) X-linked | Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
ZBED1 | Zinc finger, BED-type containing 1 | Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
CD99 | CD99 molecule | CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
XG | Xg blood group | Blood group antigen proteins Predicted membrane proteins
| | | | | Tissue enhanced |
GYG2 | Glycogenin 2 | Enzymes Predicted intracellular proteins
| | | | | Tissue enriched |
ARSD | Arylsulfatase D | Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
ARSE | Arylsulfatase E (chondrodysplasia punctata 1) | Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ARSH | Arylsulfatase family, member H | Predicted membrane proteins
| | | | | Not detected |
ARSF | Arylsulfatase F | Predicted membrane proteins
| | | | | Group enriched |
MXRA5 | Matrix-remodelling associated 5 | Cancer-related genes Predicted secreted proteins
| | | | | Mixed |
PRKX | Protein kinase, X-linked | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Tissue enhanced |
NLGN4X | Neuroligin 4, X-linked | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
VCX3A | Variable charge, X-linked 3A | Predicted intracellular proteins
| | | | | Tissue enriched |
HDHD1 | Haloacid dehalogenase-like hydrolase domain containing 1 | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
STS | Steroid sulfatase (microsomal), isozyme S | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
VCX | Variable charge, X-linked | Predicted intracellular proteins
| | | | | Tissue enriched |
PNPLA4 | Patatin-like phospholipase domain containing 4 | Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
VCX2 | Variable charge, X-linked 2 | Predicted intracellular proteins
| | | | | Tissue enriched |
VCX3B | Variable charge, X-linked 3B | Predicted intracellular proteins
| | | | | Tissue enriched |
KAL1 | Kallmann syndrome 1 sequence | Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
FAM9A | Family with sequence similarity 9, member A | Predicted intracellular proteins
| | | | | Tissue enriched |
FAM9B | Family with sequence similarity 9, member B | Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
TBL1X | Transducin (beta)-like 1X-linked | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
GPR143 | G protein-coupled receptor 143 | Disease related genes G-protein coupled receptors Potential drug targets Predicted membrane proteins
| | | | | Mixed |
SHROOM2 | Shroom family member 2 | Cytoskeleton related proteins Plasma proteins Predicted intracellular proteins
| | | | | Mixed |
AC002365.5 | Uncharacterized protein LOC100288814 | Predicted membrane proteins
| | | | | Tissue enriched |
WWC3 | WWC family member 3 | Predicted intracellular proteins
| | | | | Expressed in all |
CLCN4 | Chloride channel, voltage-sensitive 4 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
MID1 | Midline 1 | Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
HCCS | Holocytochrome c synthase | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
ARHGAP6 | Rho GTPase activating protein 6 | Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Mixed |
AMELX | Amelogenin, X-linked | Disease related genes Predicted secreted proteins
| | | | | Not detected |
MSL3 | Male-specific lethal 3 homolog (Drosophila) | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
FRMPD4 | FERM and PDZ domain containing 4 | Cytoskeleton related proteins Predicted intracellular proteins
| | | | | Tissue enriched |
PRPS2 | Phosphoribosyl pyrophosphate synthetase 2 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
TLR7 | Toll-like receptor 7 | FDA approved drug targets Predicted membrane proteins
| | | | | Mixed |
TLR8 | Toll-like receptor 8 | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
TMSB4X | Thymosin beta 4, X-linked | Cytoskeleton related proteins Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |